Log in
Enquire now
‌

US Patent 11643452 Fc-epsilon car

Patent 11643452 was granted and assigned to ImmunityBio on May, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
ImmunityBio
ImmunityBio
0
Date Filed
June 7, 2021
0
Date of Patent
May 9, 2023
0
Patent Application Number
17341098
0
Patent Citations
‌
US Patent 11129850 Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
0
‌
US Patent 11058723 Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
0
‌
US Patent 10023648 Anti-TOSO chimeric antigen receptor and its use
0
‌
US Patent 10138462 Natural killer cell lines and methods of use
0
‌
US Patent 10174095 Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
0
‌
US Patent 10765701 Elimination of CD19-positive lymphoid malignancies by CD19-CAR expressing NK cells
0
‌
US Patent 10960024 Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
0
Patent Inventor Names
Laurent H. Boissel
0
Abhijit Dandapat
0
Hans G. Klingemann
0
Himani Chinnapen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11643452
0
Patent Primary Examiner
‌
Ilia I Ouspenski
0

Find more entities like US Patent 11643452 Fc-epsilon car

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.